LEVEL OF sIgA, IgG, IgA IN VAGINAL SECRETION IN WOMEN WITH CHRONIC INFLAMMATORY DISEASE OF SMALL PELVIS ORGANS
- Authors: Shibina L.V1, Krasnoproshina L.I1, Ordiyants I.M2, Slatinova O.V1, Skhodova S.A1
-
Affiliations:
- Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
- Issue: Vol 90, No 4 (2013)
- Pages: 55-59
- Section: Articles
- Submitted: 09.06.2023
- Published: 15.08.2013
- URL: https://microbiol.crie.ru/jour/article/view/13842
- ID: 13842
Cite item
Full Text
Abstract
Aim. Determine levels of sIgA, IgG, IgA in vaginal secretion and saliva ofwomen of reproductive age with chronic inflammatory diseases of small pelvis organs (IDSPO) at exacerbation stage and remission period. Materials and methods. Clinical-laboratory and gynecological examination of 105 women was carried out. Based on the results obtained 3 groups were formed: patients with IDSPO at exacerbation stage; patients at remission stage; clinically healthy women. sIgA, IgG, IgA parameters were studied in vaginal secretion and saliva in women with IDSPO at exacerbation stage and remission period by radial immune diffusion in gel by Manchini method. Results. An increase of immunoglobulin level in vaginal secretion of women with IDSPO at remission period and a sharper increase of these parameters during exacerbation of the disease compared with women of the control group were detected. During analysis of sIgA, IgG, IgA levels in saliva in the same groups of women the results were obtained that give evidence that the presence of IDSPO and local immune reaction do not lead to the changes of these parameters. Conclusion. The obtained parameters on the dependence of an increase of immunoglobulin levels in vaginal secretions and the degree of intensity of the inflammatory process give basis to use them with the aim of additional diagnostics.
About the authors
L. V Shibina
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
L. I Krasnoproshina
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
I. M Ordiyants
O. V Slatinova
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
S. A Skhodova
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
References
- Нестеров И.М., Тотолян А.А. Иммунокорригирующая терапия инфекционновоспалительных заболеваний женской половой сферы. Санкт-Петербург, 2007.
- Плужников М.С., Лавренова Г.В., Левин М.Я. и др. Иммунология хронического тонзиллита. В: Тонзиллит: клинические и иммунологические аспекты. СПб, Диалог, 2004.
- Резников Ю. П. Иммунология в клиническом лабиринте. М., Тверь, Триада, 2007.
- Серов В.Н., Тихомиров А.Л., Лубнин Д.М. Современные принципы терапии воспалительных заболеваний женских половых органов. Методическое пособие. М., 2003.
- Хаитов Р. М., Борисова А. М. Рибомунил: коррекция иммунной системы у больных хроническим бронхитом. Прил. к межд. мед. журн. Медикал маркет. 1995, 1: 18-19.
- Hocini H., Barra A., Belec L. et al. Systemic and secretory humoral immunity in the normal human vaginal tract. J. Immunol. 1995, 42: 269.
- Kutteh W. H., Mestecky Y Secretory immunity in the female reproductive tract. Am. J. Reprod. Immunol. 1994, 31: 40.
- Kutteh W. H., Wester R., Prince S. J. et al. Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin. Immunol. 1996, 104: 538-542.